Presenting a lecture entitled, "Modeling human immunity, disease, and even human organs in NextGEN humanized mice," Richard Flavell, PhD, FRS will be the featured speaker at the 23rd Annual D. Bernard Amos Research Lecture.
Dr. Flavell is the Sterling Professor of Immunobiology at Yale University School of Medicine, and an Investigator of the Howard Hughes Medical Institute. He received his B.Sc. (Honors) in 1967 and Ph.D. in 1970 in biochemistry from the University of Hull, England, and performed postdoctoral work in Amsterdam (1970-72) with Piet Borst and in Zurich (1972-73) with Charles Weissmann. Before accepting his current position in 1988, Dr. Flavell was first Assistant Professor (equivalent) at the University of Amsterdam (1974-79); then Head of the Laboratory of Gene Structure and Expression at the National Institute for Medical Research, Mill Hill, London (1979-82); and subsequently President and Chief Scientific Officer of Biogen Research Corporation, Cambridge, Massachusetts (1982-88). Dr. Flavell is a fellow of the Royal Society, a member of the National Academy of Sciences as well as the National Academy of Medicine. Richard Flavell uses transgenic and gene-targeted mice to study Innate and Adaptive immunity, T cell tolerance and activation in immunity and autoimmunity, apoptosis, and regulation of T cell differentiation.
Agenda
11:30am Seminar (143 Jones)
2pm - 4pm: Poster Contest (1st floor lobby, MSRB III)
4pm: Reception (1st floor lobby, MSRB III)
About the Lecture
The D. Bernard Amos Research Lecture is supported by the D. Bernard Amos Fellowship Endowment. The lecture was established by the Department of Immunology to honor his memory and recognize his many contributions to medical research, education and service. A poster competition provides trainees with the opportunity to showcase their work and win awards. This event is facilitated by a student committee. Students and postdocs are invited to all speaker lunches as a networking opportunity after each seminar. Seminar refreshments are provided.